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Introduction
Neuropsychiatric systemic lupus erythematosus (NPSLE)
is a diagnostically challenging, severe, and life-threatening
condition. Neuroimaging techniques such as magnetic
resonance imaging (MRI) are increasingly used to assist
the diagnosis and monitoring of the disease course in
adults with NPSLE. The role of MRI in the evaluation of
children and adolescents with suspected juvenile NPSLE
is however unknown.
Objectives
The aim of this study was to describe the abnormalities
identified with conventional MRI in children with NPSLE;
and any potential associations with clinical and/or
serological markers presenting to a tertiary paediatric
rheumatology service.
Methods
Single centre (Great Ormond Street Hospital NHS
Foundation Trust, London) retrospective case series of
patients with juvenile NPSLE seen between April 2003
and October 2010. Contrast enhanced brain MR images
of the first episode of active NPSLE were reviewed. All
patients fulfilled the American College of Rheumatology
(ACR) 1982 revised criteria for the classification of SLE
and were classified according to the 1999 ACR case
definition for NPSLE syndromes. We excluded patients
with a history of alternative neurological conditions.
Presenting neuropsychiatric manifestations, immunologi-
cal findings and treatment are reported. Continuous vari-
ables are summarised as median and ranges. Categorical
variables are presented as percentages. Fisher’s exact test
was used to identify the probability of abnormal MRI
findings.
Results
A total of 27 patients median age 11 (4-15) years, 22
females with suspected juvenile NPSLE were studied.
Presenting clinical symptoms included: headaches (85.1%);
mood disorder/depression (62.9%); seizures (22.2%); acute
psychosis (18.5%); cognitive dysfunction (14.8%); move-
ment disorder (14.8%); acute confusional state (14.8%);
aseptic meningitis (7.4%); demyelinating syndrome (3.7%);
myelopathy (3.7%); dysautonomia (3.7%); and cranial
neuropathy (3.7%). The principal MR findings were: 1)
absence of MRI abnormalities despite signs and symptoms
of active NPSLE (59% of all patients); 2) focal hyperinten-
sities on T2-weighted imaging in both white and grey
matter (33%); 3) diffuse cortical grey matter lesions (3.7%);
and 4) diffuse brain atrophy (18.5%). The presence of>2
neuropsychiatric manifestations strongly associated with
abnormal MRI findings (p = 0.014). Positive dsDNA
antibodies were noted in 74% of patients; positive extra
nuclear antibodies in 74%, lupus anticoagulant in 15% and
anticardiolipin antibodies in 37%. All children were treated
with hydroxychloroquine and high doses of intravenous
corticosteroids while other treatments used were: intrave-
nous cyclophosphamide (51.8%); rituximab (40.7%); and
plasma exchange (11.1%).
Conclusion
In the present study, no conventional MRI abnormalities
were observed in the majority of patients with clinically
active NPSLE. The presence of >2 neuropsychiatric
manifestations was strongly associated with abnormal
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